Nano Meat

Nanomeat has pioneered a food-tech innovation that drastically reduces the production cost of cultivated meat, making it cost-effective for the first time ever. The company was founded in collaboration with Volcani Institute. Patent protected te

0% of funding target


Units left


Minimum investment


Days to go
By: Eyal Brilant
Angel Investment
Investment type:
Company Stage:
Food & Agro



Game-Changing Technology – Overcoming the Cost Barrier for Cultivated Meat Production

Nanomeat offers a unique and groundbreaking solution to a critical problem in the cultivated meat production industry: the high cost of growth media. Leveraging their cutting-edge technology, Nanomeat optimizes the utilization of cell nutrients, resulting in a remarkable 99% increase in process efficiency while substantially reducing costs. The impact of this innovation is profound, as it enables the production of cultivated bovine meat to be profitable for the first time ever. By significantly reducing the barriers to entry, Nanomeat's technology paves the way for a more sustainable, ethical, and affordable future of meat consumption.



Strategic partnership with a governmental research institute

Nanomeat was founded and operates in collaboration with a governmental research institute - the largest institution in Israel engaged in agricultural research and a global leader in innovation. This unique partnership minimizes the company's operational costs, allowing it to allocate the majority of its resources to research and development, providing significant advantages over its competitors.


Patented Technology

The company holds registered patents for its technology, giving it a competitive IP advantage over other companies in the industry.


A world-class team of professors and researchers

Nanomeat takes pride in its team of talented experts in the fields of food technology, molecular biology, and chemical engineering.

Led by a professor and a doctor, who serve as a senior scientist and head of a leading laboratory in the country, collectively holding dozens of patents and authoring numerous scientific articles.


Addressing a Growing Market

The global demand for animal products, including meat, is continuously rising. According to market researchers, Nanomeat taps into the growing market of cultivated meat, which could become a multi-billion-dollar industry by 2030. Their solution addresses the need for more affordable cultivated meat production, making it an attractive option for cultivated meat producers worldwide.



What is lab-grown meat?

Lab-grown meat, also known as cultivated meat or cell-based meat, is a real meat that is produced in a clean, sterile environment, and does not require the slaughter of an animal.

The process typically involves taking a small sample of cells from an animal, such as muscle tissue, and then using these cells to grow meat in a lab setting. The cells are placed in a nutrient-rich medium that allows them to multiply and grow into muscle tissue. This tissue can then be harvested and processed into meat products.


Why do we need it?

According to the scientific publication, the world had consumed about 76 million tons of bovine meat in 2021 alone. As global population continues to rise annually, there doesn’t seem to be any slowdown for global demand for animal products, including meat, bovine or other.

Cultivated meat is seen as a more sustainable, ethical and healthy alternative to traditional meat production. It requires fewer resources such as land, water, and energy, and produces fewer greenhouse gas emissions. Additionally, lab-grown meat is produced without the need to raise and slaughter animals, thus addressing animal welfare concerns. From a health perspective, lab-grown meat can be produced without the use of antibiotics or hormones, potentially reducing health risks associated with conventional meat consumption. Furthermore, the controlled environment of lab-grown meat production reduces the risk of foodborne illnesses compared to traditional meat production methods.

As the global population continues to grow, lab-grown meat also offers a solution to food security challenges by providing a more efficient and sustainable way to produce meat. Moreover, the customizable nature of lab-grown meat production allows for the creation of meat products tailored to meet specific consumer preferences and dietary needs.

Overall, lab-grown meat has the potential to revolutionize the ever-growing meat industry, offering several significant benefits to conventional meat.




The Challenge

While cultivated meat offers several potential benefits, there are also some challenges and concerns associated with its production and adoption. Currently, the production of lab-grown meat is too expensive, primarily due to the high cost of the growth medium and the energy-intensive process of cell cultivation (growth factors). As a result, lab-grown meat is not yet cost-competitive with traditional meat products.



The Solution

Nanomeat has introduced a groundbreaking solution to address the issue of serum cost in the cultivated meat industry. By leveraging advanced manufacturing and targeting technology, they optimize the utilization of growth factors during the production of cultivated meat. Nanomeat technologies effectively produce, capture and deliver growth factors directly to the meat target cells. This innovative approach enhances the efficiency of the process by an impressive level of up to several hundred fold and significantly reduces the amount of serum required for cell culture. As a result, the volume of growth factors needed to grow a kilogram of meat is reduced to only around 1-10% of the current requirements. The substantial decrease in serum usage, coupled with improved efficiency, leads to notable cost reductions for cultivated meat manufacturers. Nanomeat's ultimate aim is to enable the production of affordably-priced cultivated beef meat, priced at approximately 36% of the current price for a kilogram of regular beef meat.


The Technology

The technologies are:

  1. Edible "Micro-factories" that are added into the cultivated meat culture and produce highly effective growth factors;
  2. Nano-based technology for targeted delivery of essential factors to cultivated meat cells.





Liat Bidas
Co - Founder
Active in the capital market for over 15 years, and serving as a managing partner at "Apstrim Capital," which deals in investments, financial transactions, and mergers in the capital market. A managing partner at the publicly traded investment fund on the TASE, "Biomit Foodtech," which specializes in investments in the plant-based protein and cultured meat sectors. Ms. Bids has extensive practical experience in the enhancement and support of companies, both in executive roles and as an investor, including guiding the company from the development stage, conducting experiments, obtaining regulatory approvals, and up to the marketing and sales stage of the final product. Ms. Bids has experience in employee management, initiating and leading companies to profitability. She has many years of experience in the capital market and investment sector, and the ability to assist target companies in business consulting and establishing connections with financial investors and strategic investors.

  • Founder
  • Key Employee

Financial data

Financial data



Currently there are no updates in this pitch

The financing rounds, made through the ExitValley platform, are in accordance with a model of statutory exemption from publishing a prospectus pursuant to sections 15A(A)(1) and 15A(A)(7) of the Israeli Securities Law - 1968.
Under this model, the disclosure of detailed information on the company and information about the investment in each round of financing are limited to not more than 35 investors, who are not qualified investors, and the round of financing is not in the format of an offering arrangement ("רכז הצעה"), as defined in the Securities Law.
Follow us